BRPI0820861A2 - Dispersible oral tablet - Google Patents

Dispersible oral tablet

Info

Publication number
BRPI0820861A2
BRPI0820861A2 BRPI0820861-1A BRPI0820861A BRPI0820861A2 BR PI0820861 A2 BRPI0820861 A2 BR PI0820861A2 BR PI0820861 A BRPI0820861 A BR PI0820861A BR PI0820861 A2 BRPI0820861 A2 BR PI0820861A2
Authority
BR
Brazil
Prior art keywords
oral tablet
dispersible oral
dispersible
tablet
oral
Prior art date
Application number
BRPI0820861-1A
Other languages
Portuguese (pt)
Inventor
Tobias Laich
Thomas Steenpass
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0820861A2 publication Critical patent/BRPI0820861A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0820861-1A 2007-12-08 2008-11-25 Dispersible oral tablet BRPI0820861A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07023802 2007-12-08
PCT/EP2008/009968 WO2009071219A2 (en) 2007-12-08 2008-11-25 Oral dispersable tablet

Publications (1)

Publication Number Publication Date
BRPI0820861A2 true BRPI0820861A2 (en) 2015-06-16

Family

ID=40631079

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820861-1A BRPI0820861A2 (en) 2007-12-08 2008-11-25 Dispersible oral tablet

Country Status (9)

Country Link
EP (1) EP2231126A2 (en)
JP (2) JP2011506279A (en)
KR (1) KR20100096140A (en)
CN (1) CN101888834A (en)
BR (1) BRPI0820861A2 (en)
MX (1) MX2010005175A (en)
RU (1) RU2010128019A (en)
TW (1) TW200938233A (en)
WO (1) WO2009071219A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120156293A1 (en) * 2009-09-08 2012-06-21 Hideaki Kitajima Antacid and laxative tablet
CN101797236B (en) * 2010-03-23 2012-05-23 西南大学 Rivastigmine orally disintegration tablet and preparation method thereof
PH12012502139A1 (en) * 2010-04-27 2022-03-21 Bayer Ip Gmbh Orally disintegrating tablet containing acarbose
US20110300216A1 (en) * 2010-06-03 2011-12-08 First Eric R Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
JP5750856B2 (en) * 2010-10-04 2015-07-22 ライオン株式会社 Solid pharmaceutical composition and pharmaceutical preparation
KR101237646B1 (en) * 2010-12-09 2013-03-04 주식회사 드림파마 Solid dispersion comprising celecoxib with improved bioavailibity, pharmaceutical composition comprising the solid dispersion, and preparation method of the solid dispersion
FR2968995B1 (en) * 2010-12-16 2013-03-22 Sanofi Aventis PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION TO PREVENT MEASUREMENT
FR2968992B1 (en) * 2010-12-16 2013-02-08 Sanofi Aventis ORODISPERSIBLE PHARMACEUTICAL TABLET BASED ON ZOLPIDEM
TR201100150A2 (en) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Water soluble dosage forms
WO2013115741A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Pharmaceutical compositions comprising alpha-glucosidase inhibitor
CN102600149B (en) * 2012-02-02 2013-12-04 西藏易明西雅生物医药科技有限公司 Pharmaceutical composition for treating diabetes
US20160136091A1 (en) 2013-07-19 2016-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Orally Disintegrating Tablet
EP3021837A1 (en) * 2013-07-19 2016-05-25 Bayer Pharma Aktiengesellschaft Super quick disintegrating tablet formula for api miglitol
CN103877041B (en) * 2014-03-14 2016-07-06 崔书豪 A kind of piroxicam dispersible tablet and preparation method thereof
CN115919894A (en) 2016-01-29 2023-04-07 株式会社Kit Solid preparation, preparation method of solid preparation and hydrogen evolution method
CN105640954B (en) * 2016-02-04 2019-03-05 青岛市海慈医疗集团 It is a kind of to treat dyspeptic Cisapride tablet
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11786471B2 (en) * 2016-07-11 2023-10-17 Wuhan Ll Science And Technology Development Co. Ltd. Complex disintegrant system for oral solid preparation and oral solid preparation comprising said complex disintegrant system
CN110191860A (en) 2016-08-23 2019-08-30 小林光 Formulation, its production method, and hydrogen supply method
CN110191699A (en) 2016-08-23 2019-08-30 小林光 Hydrogen supply material, method for producing the same, and method for supplying hydrogen
CN107334742B (en) * 2017-08-18 2020-01-31 山东力诺制药有限公司 fluoxetine hydrochloride dispersible tablet and preparation method thereof
WO2019066555A1 (en) * 2017-09-28 2019-04-04 Hanmi Pharm. Co., Ltd. Pharmaceutical composition including multi-unit spheroidal tablet containing esomeprazole and spheroidal pharmaceutically acceptable salt thereof, and method of preparing the pharmaceutical composition
CN110840850B (en) * 2018-07-24 2023-03-17 烟台药物研究所 Celecoxib freeze-dried orally disintegrating tablet with high bioavailability and preparation method thereof
CN109864971B (en) * 2019-04-08 2021-12-17 西安远大德天药业股份有限公司 Granules of lamotrigine solid dispersion and preparation method thereof
CN114224855B (en) * 2021-12-01 2023-11-28 北京悦康科创医药科技股份有限公司 Doxazosin mesylate buccal tablet and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802700A1 (en) * 1998-01-24 1999-07-29 Bayer Ag Preparation of fast-dissolving tablets for controlling blood sugar levels
CN1688291A (en) * 2002-02-01 2005-10-26 辉瑞产品公司 Immediate release dosage forms containing solid drug dispersions
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
JP4739217B2 (en) * 2003-05-07 2011-08-03 サムヤン コーポレイション Highly plastic granules for making fast dissolving tablets
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20070196477A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly dissolving tablets comprising low surface area calcium phosphates
US20070196474A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly disintegrating low friability tablets comprising calcium carbonate
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
MX2010005175A (en) 2010-08-02
JP2011506279A (en) 2011-03-03
WO2009071219A2 (en) 2009-06-11
TW200938233A (en) 2009-09-16
JP2015038123A (en) 2015-02-26
RU2010128019A (en) 2012-01-20
CN101888834A (en) 2010-11-17
WO2009071219A3 (en) 2009-09-11
EP2231126A2 (en) 2010-09-29
KR20100096140A (en) 2010-09-01

Similar Documents

Publication Publication Date Title
LTC2498758I2 (en) TWO-LAYER TABLET FORMULATIONS
NL301011I2 (en) pegvaliasis
BRPI0808889A2 (en) ORAL DISINTERRANTING PILL
EP2251005A4 (en) ORAL CRUMPING TABLETS
DK4218732T3 (en) TABLETS COMPRISING ELTROMBOPAG-OLAMINE
DK2077729T3 (en) ORAL PROBIOTIC DOSAGE FORMS
BRPI0820381A2 (en) Pharmaceutical Formulations
DE602007010442D1 (en) DISPERSIBLE HUMIDIFINES
DE602008006310D1 (en) Endoscopic re-processor
BRPI0812350A2 (en) CONNECTION
EP2045016A4 (en) MILL
PT2173888T (en) SUMMARY
DK2155586T3 (en) Capsule for dispersible materials
BRPI0920521A2 (en) pharmaceutical combination
BRPI0908114A2 (en) controlled release oral tablet
EP2176032A4 (en) JAW SET
BRPI0819231A2 (en) Oral Disintegrating Dosage Form
BRPI0814188A2 (en) FORMULATIONS
BRPI0812916A2 (en) PACIFIER
EP2133092A4 (en) Oral vaccine
DK2194959T3 (en) Foam-proof oral care preparation
GB0710439D0 (en) Oral dosage form
BRPI0821735A2 (en) Tablet Manufacturing
EP2197448A4 (en) DOSAGE DIAGRAM
DK2176002T3 (en) CYCLONE DEVICE

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.